Decreased susceptibility to copper-induced oxidation of rat-lipoproteins after fibrate treatment: Influence of fatty acid composition

British Journal of Pharmacology

Volumn 117, Issue 6, 1996, Pages 1155-1162

  Vázquez, Manuel ^a   Merlos, Manuel ^a   Adzet, Tomás ^a   Laguna, Juan C ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Bezafibrate; Clofibrate; Copper oxidation; Fatty acids; Gemfibrozil; Rat low density lipoprotein (LDL); Rat VLDL

Indexed keywords

BEZAFIBRATE; CHOLESTEROL; CHOLESTEROL ESTER; CLOFIBRATE; COPPER; FATTY ACID; FIBRIC ACID DERIVATIVE; GEMFIBROZIL; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; LYSINE; MONOUNSATURATED FATTY ACID; POLYUNSATURATED FATTY ACID; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DRUG EFFICACY; FATTY ACID TRANSPORT; LIPID COMPOSITION; LIPID OXIDATION; LIPOPROTEIN BLOOD LEVEL; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0029883688     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1476-5381.1996.tb16710.x     Document Type: Article

References (31)

1. AGHELI, N. & JACOTOT, B. (1991). Effect of simvastatin and fenofibrate on the fatty acid composition of hypercholesterolaemic patients. Br. J. Clin. Pharmacol., 32, 423-428.
2. ALEGRET, M., CERQUEDA, E., FERRANDO, R., VAZQUEZ, M., SANCHEZ, R.M., ADZET, T., MERLOS, M. & LAGUNA, J.C. (1995). Selective modification of rat hepatic microsomal fatty acid chain elongation and desaturation by fibrates. Relationship with their activity as peroxisome proliferators. Br. J. Pharmacol., 114, 1351-1358.
3. ALEGRET, M., FERRANDO, R., VAZQUEZ, M., ADZET, T., MERLOS, M. & LAGUNA, J.C. (1994). Relationship between plasma lipids and palmitoyl-CoA hydrolase and synthetase activities with peroxisomal proliferation in rats treated with fibrates. Br. J. Pharmacol., 112, 551-556.
4. ASHBY, J., BRADY, A., ELCOMBE, C.R., ELLIOTT, B.M., ISHMAEL, J., ODUM, J., TUGWOOD, J.D., KETTLE, S. & PURCHASE, I.F.H. (1994). Mechanistically-based human hazard assessment of peroxisome proliferator induced hepatocarcinogenesis. Human Exp. Toxicol., 13, S87-S92.
5. AVIRAM, M., DANKNER, G., COGAN, U , HOCHGRAF, E. & BROOK, J.G. (1992). Lovastatin inhibits low-density lipoprotein oxidation and alters its fluidity and uptake by macrophages: in vitro and in vivo studies. Metabolism, 41, 229-235.
6. BERRY, E.M., EISENBERG, S, HARATZ, D., FRIEDLANDER, Y., NORMAN, Y., KAUFMANN, N.A. & STEIN, Y. (1991). Effects of diets rich in monounsaturated fatty acids on plasma lipoproteins. The Jerusalem nutrition study. II. Monounsaturated fatly acids vs. carbohydrates. Am. J. Clin. Nutr., 53, 899-907.
7. BLIGH, E.G. & DYER, W.J. (1959). A rapid method for total lipid extraction and purification. Can. J. Biochem. Physiol., 37, 911-917.
8. BRADFORD, M. (1976). A rapid sensitive method for the quantitation of microgram quantities of protein utilizing the principles of protein-dye binding. Anal. Biochem., 72, 248-254.
9. ESTERBAUER, H., GEBICKI, J., PUHL, H. & JURGENS, G. (1992). The role of lipid peroxidation and antioxidants in oxidative modification of LDL. Free Rad. Biol. Med., 13, 341-390.
10. ESTERBAUER, H., STRIEGL, G., PUHL, H. & ROTHENEDER, M. (1989). Continuous monitoring of in vitro oxidation of human low density lipoprotein. Free Rad. Res. Commun., 6, 67-75.
11. GLAUERT, H.P., SRINIVASAN, S., TATUM, V.L. CHEN, L.-C., SAXON, D.M., LAY, L.T., BORGES, T., BAKER, M., CHEN, L.H., ROBERTSON, L.W. & CHOW, C.K. (1992). Effects of peroxisome proliferators clofibrate and perfluorodecanoic acid on hepatic cellular antioxidants and lipid peroxidation in rats. Biochem. Pharmacol., 43, 1353-1359.
12. HAWKINS, J.M., JONES, W.M., BONNER, F.W. & GIBSON, G.G. (1987). The effect of peroxisome proliferators on microsomal, peroxisomal and mitochondrial enzyme activities in the liver and kidney. Drug Metab. Rev., 18, 441-515.
13. HIDA, Y., FURUKAWA, Y., URANO, T., KIM, H.J. & KIMURA, S. (1993). Substrate specificity of rat plasma lecithin-cholesterol acyltransferase towards a molecular species of phosphatidylcholine. Biosci. Biotech. Biochem., 57, 1111-1114.
14. HOFFMAN, R., BROOK, G.J. & AVIRAM, M. (1992). Hypolipidemic drugs reduce lipoprotein susceptibility to undergo lipid peroxidation: in vitro and ex vivo studies. Atherosclerosis, 93, 105-113.
15. JURAND, J. & OLIVER, M.F. (1963). The effects of ethylchlorophenoxyisobutirate on serum cholesteryl, triglyceride and phospholipid fatty acids. J. Atheroscler. Res., 3, 547-553.
16. KLEINVELD, H.A., HAK-LEMMERS, H.L.M., STALENHOEF, A.F.H & DEMACKER, P.M.N. (1992). Improved measurement of low-density-lipoprotein susceptibility to copper-induced oxidation: Application of a short procedure for isolating low-density lipoprotein. Clin. Chem., 38, 2066-2072.
17. MAO, T., YATES, T., RECHTIN, E., JACKSON, L. & VAN SICKLE, A. (1991). Antioxidant antivity of probucol and its analogues in hypercholesterolemic Watanabe rabbits. J. Med. Chem., 34, 298-302.
18. MAXWELL, R.E., NAWROCKI, J.W. & UHLENDORF, P.D. (1983). Some comparative effects of gemfibrozil, clofibrate, bezafibrate, cholestyramine and compactin on sterol metabolism in rats. Atherosclerosis, 48, 195-203.
19. MILLS, G.L., LANE, P.A. & WEECH, P.K. (1984). The isolation and purification of plasma lipoproteins. In A Guidebook of Lipoprotein Technique. Laboratory Techniques in Biochemistry and Molecular Biology, ed. Burdon, R.H. & van Knippenberg, P.H. pp. 64-77. Amsterdam: Elsevier Science Publishers.
20. SCACCINI, C., NARDINI, M., D'AQUINO, M., GENTILI, V., DI FELICE, M. & TOMASSI, G. (1992). Effect of dietary oils on lipid peroxidation and on antioxidant parameters of rat plasma and lipoprotein fractions. J. Lipid Res., 33, 627-633.
21. SIRTORI, C.R., CALABRESI, L., WERBA, J.P. & FRANCESCHINI, G. (1992). Tolerability of fibric acids. Comparative data and biochemical bases. Pharmacol. Res., 26, 243-260.
22. SUCKLING, K.E. & JACKSON, B. (1993). Animal models of human lipid metabolism. Prog. Lipid Res., 32, 1-24.
23. TAVELLA, M., CORDER, C.N. & MCCONATHY, W. (1993). Effect of gemfibrozil on fatty acids in lipid fractions of plasma from patients with hypertriglyceridemia. J. Clin. Pharmacol., 33, 35-39.
24. VANCE, J.E. (1989). The use of newly synthesized phospholipids for assembly into secreted hepatic lipoproteins. Biochim. Biophys. Acta, 1006, 59-69.
25. VANCE, J.E. & VANCE, D.E. (1990). Lipoprotein assembly and secretion by hepatocytes. Annu. Rev. Nutr., 10, 337-356.
26. VAZQUEZ, M., ALEGRET, M., ADZET, T., MERLOS, M. & LACUNA, J.C. (1993). Gemfibrozil modifies acyl composition of liver microsomal phospholipids from guinea-pigs without promoting peroxisomal proliferation. Biochem. Pharmacol., 46, 1515-1518.
27. VAZQUEZ, M., MUÑOZ, S., ALEGRET, M., ADZET, T., MERLOS, M. & LAGUNA, J.C. (1995). Fibrates show differential effects on the acyl composition of microsomal phospholipids in rats. Br. J. Pharmacol., 116, 2067-2075.
28. VESSBY, B., LITHELL, H., GUSTAFSSON, I.-B. & BOBERG, J. (1980a). Changes in the fatty acid composition of the plasma lipid esters during lipid-lowering treatment with diet, clofibrate and niceritrol. Reduction of the proportion of linoleate by clofibrate but not by niceritrol. Atherosclerosis, 35, 51-65.
29. VESSBY, B., LITHELL, H., HELLSING, K., OSTLUND-LINDQVIST, A.-M., GUSTAFSSON, I.-B., BOBERG, J. & LEDERMANN, H. (1980b). Effects of bezafibrate on the serum lipoprotein lipid and apolipoprotein composition, lipoprotein triglyceride removal capacity and the fatty acid composition of the plasma lipid esters. Atherosclerosis, 37, 257-269.
30. WANG, C.-S., HARTSUCK, J. & MCCONATHY, W.J. (1992). Structure and functional properties of lipoprotein lipase. Biochim. Biophys. Acta. 1123, 1-17.
31. WEISS, P. & BIANCHINE, J.R. (1970). The effect of clofibrate on vitamin E concent rations in the rat. Atherosclerosis, 11, 203-205.